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Aging is accompanied by gradually increasing impairment of cognitive abilities and
constitutes the main risk factor of neurodegenerative conditions like Alzheimer’s disease
(AD). The underlying mechanisms are however not well understood. Here we analyze the
hippocampal transcriptome of young adult mice and two groups of mice at advanced age
using RNA sequencing. This approach enabled us to test differential expression of coding
and non-coding transcripts, as well as differential splicing and RNA editing. We report a
specific age-associated gene expression signature that is associated with major genetic
risk factors for late-onset AD (LOAD). This signature is dominated by neuroinflammatory
processes, specifically activation of the complement system at the level of increased
gene expression, while de-regulation of neuronal plasticity appears to be mediated by
compromised RNA splicing.
Keywords: inflammaging, RNA-editing, innate immune system, RNA-seq, neuroinflammation, synaptic plasticity,
learning and memory, gene-environment interaction
INTRODUCTION
Aging is associated with a number of changes that affect cel-
lular homeostasis and impact on the organism’s overall health.
Aging also leads to a decline of cognitive function including
memory formation across species. As such, age-associated mem-
ory impairment is observed in invertebrates such as flies as
well as in rodents and humans (Horiuchi and Saitoe, 2005;
Bishop et al., 2010; Verdaguer et al., 2012). While in humans
age is the most significant risk factor for neurodegenerative
diseases such as Alzheimer’s disease (AD), it is important to
note that the degree of cognitive decline varies significantly on
an individual level. Thus, some individuals undergo so-called
“healthy/successful aging” that is characterized by relatively intact
cognitive function, while others develop severe memory impair-
ments and in the most extreme case dementia (Koivisto et al.,
1995; Montesanto et al., 2012). In humans it is believed that the
manifestation of healthy cognitive aging vs. dementia depends on
the variable combinations of genetic pre-disposition and envi-
ronmental factors an individual experiences throughout lifetime
(Fischer, 2014). In order to decipher the molecular signature
of age-associated memory impairment it is therefore most suit-
able to rely on mouse studies in which the genetic background
and the environmental factors can be tightly controlled. The
mean life span of different mouse strains housed in a laboratory
ranges from about 24–30months (Jucker and Ingram, 1997; Peleg
et al., 2010). Previous studies have demonstrated that the onset
of age-associated memory impairment in mice can already be
observed at 16–18 months of age and is prominent at 24 months
of age, while assessment of cognitive function becomes more dif-
ficult at more advanced ages due to impaired motor function
(Berchtold et al., 2008; Peleg et al., 2010). It has been speculated
that age-associated memory decline is correlated to a gene expres-
sion signature that dictates cellular plasticity. As such, a number
of studies reported altered gene expression in the aging brain
using targeted approaches such as qPCR or microarray (Finch
and Morgan, 1990; Pletcher et al., 2002; Blalock et al., 2003, 2010;
Lu et al., 2004; Verbitsky et al., 2004; Xu et al., 2007; Zahn et al.,
2007; Loerch et al., 2008; Pawlowski et al., 2009; Bishop et al.,
2010). Unlike these approaches, RNA sequencing is not biased by
probe design and in addition to the identification of differential
gene expression readily allows the analysis of alternative splicing
and RNA editing, two processes intimately linked to cognitive
function. RNA sequencing is widely used in other fields and is
now also more commonly applied to study brain tissue (Dillman
et al., 2013; Mazin et al., 2013; Wood et al., 2013; Stilling et al.,
2014). However, the aging hippocampus, a key region formemory
formation in rodents and humans that is affected early in age-
associated memory decline and AD, has not been studied using
RNA sequencing. To this end, we used Illumina next-generation
sequencing to compare the hippocampal transcriptomes of 3, 24,
and 29-month-old C57BL/6J mice (3M, 24M, and 29M, respec-
tively). We find that the aging hippocampus is characterized by
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a strong neuroinflammatory gene-expression signature that is
dominated by differential gene expression but not by differential
splicing or RNA-editing. A key component of the neuroinflam-
matory response was activation of the complement system that
has repeatedly been genetically linked to AD (Bertram et al., 2007;
Lambert et al., 2009; Brouwers et al., 2012). Taking into account
that neuroinflammation is a keymechanism in neurodegenerative
diseases, our data supports the view that AD may represent accel-
erated brain aging due to an unfavorable genetic pre-disposition
and exposure to environmental risk factors. On the other hand,
we find that compromised synaptic function is linked predomi-
nantly to alternative splicing suggesting that, on the level of the
transcriptome, age-associated neuroinflammation and decreased
synaptic plasticity are mediated by distinct cellular processes.
MATERIALS AND METHODS
ANIMALS
Specific pathogen free (SPF) C57Bl6/J wild type mice were
obtained from Janvier SAS. Mice were kept in groups ≤5 animals
in individually ventilated cages (32 × 16 × 14 cm, Techniplast)
on a 12 h light/dark cycle with food and water ad libitum. To
obtainmice between 28 and 30months of age, 24month-oldmice
were ordered from Janvier SAS and kept in our holding rooms
for 4–6 months. All procedures were performed by experienced
experimenters and according to protocols approved by the Lower
Saxony State Office for Consumer Protection and Food Safety.
NOVEL OBJECT RECOGNITION
Behavioral testing was performed as described previously
(Kerimoglu et al., 2013). Animals were habituated individually
to a uniform-gray plastic arena (90 × 90 cm, walls 20 cm high)
for 5min on two subsequent days. Animals were then further
habituated to two equal objects placed in opposing corners of
the arena for 5min on the next two days. On day 5 objects were
exchanged by two new but equal objects (A + A) and animals
were allowed to explore the objects for 5min. Then, mice were
sent back to their home cages for 5min (for short-term memory
assessment) and reintroduced to the arena after one object was
exchanged (objects A+ B). After 24 h, object B was exchanged for
object C for long-term memory assessment. Duration of object
contacts was measured. Mice that only showed summed contact
time of <1 s were excluded from the analysis of this test. Object
preference was defined as (novel object)/sum(both objects).
RNA EXTRACTION AND SEQUENCING
Total RNA was extracted using TRI Reagent (Sigma-Aldrich) as
previously described (Peleg et al., 2010). In brief, flash-frozen
tissue was homogenized on ice with several pestle strokes in
0.5ml of TRI Reagent (Sigma-Aldrich) After addition of another
0.5ml of TRI Reagent and 5min incubation at room temper-
ature (RT) the dissociated homogenate was mixed with 300μl
of CHCl3 and incubated for 15min (RT) followed by cen-
trifugation at 12,000× g (4◦C). The upper aqueous phase was
transferred to a new tube, mixed with 500μl isopropanol and
incubated at -20◦C for at least 1 h for precipitation. RNA was
precipitated by centrifugation at 12,000 g for 30min (4◦C). The
pellet was washed twice with 1ml of 75% ethanol (centrifugation
after washing steps: 12,000× g, 5min, 4◦C). The washed pellet
was dissolved in 30μl of RNase-free water. Following DNase1
(life Technologies) treatment to remove residual contaminat-
ing genomic DNA for 20min at 37◦C, RNA was purified using
phenol-chloroform extraction. Library preparation and cluster
generation for mRNA sequencing [single-end libraries for 3M
(n = 5) vs. 24M (n = 6) comparison; paired-end libraries for
3M vs. 29M comparison (n = 3)] was performed according
to Illumina standard protocols using the TruSeq RNA Sample
Prep Kit v2 and the TruSeq Paired-End Cluster Generation
Kit v3-cBot-HS (for paired-end mRNA-seq) with subsequent
use of the corresponding TruSeq Cluster Generation Kit v3-
cBot-HS (for single-end mRNA-seq). Libraries were quality
controlled and quantified using a Nanodrop 2000 (Thermo
Scientific), an Agilent 2100 Bioanalyzer (Agilent Technologies)
and Qubit (life Technologies). For the sequencing run, TrueSeq
SBS kits were used according to Illumina manuals. Read lengths
were 1 × 50 bp for single-end and 2 × 100 bp for paired-end
sequencing.
BIOINFORMATIC ANALYSIS PIPELINE
Differential gene expression
Differential gene expression analysis of RNA sequencing data
was performed as described previously (Stilling et al., 2014).
In brief, library preparation [single-end libraries for 3-month
(3M) (n = 5) vs. 24-month (24M) (n = 6) comparison;
paired-end libraries for 3M vs. 29-month (29M) comparison
(n = 3)] and cluster generation for mRNA sequencing were
performed as required by Illumina protocols (TruSeq, Illumina).
Downstream analysis steps after read retrieval included quality
control (FastQC, www.bioinformatics.babraham.ac.uk/projects/
fastqc/) and mapping to reference genome (STAR aligner v2.3.0,
Dobin et al., 2013). For calling of differentially expressed genes
(DEG), mapped reads were counted with HTSeq v0.5.4p2
(http://www-huber.embl.de/users/anders/HTSeq) (non-default
parameters: -m intersection non-empty) and count tables were
analyzed independently for both aging groups vs. the 3M young
control group using the DESeq2 v1.2.5 R-package (Anders and
Huber, 2010). Genes with a log2(fold-change) ≥ 0.5 and adjusted
p-value ≤ 0.05 were considered differentially regulated. All
expression data are made publicly available in a GEO SuperSeries
(GSE61918). Compressed fastq-files and primary analysis can be
found under GEO accession GSE61915, microarray raw data is
available under GEO accession GSE61647.
Functional annotation
Functional annotation and category and pathway analysis was
carried out using the Database for Annotation, Visualization, and
Integrated Discovery (DAVID, v6.7) (Huang et al., 2009a,b). Non-
cutoff-based gene set enrichment analysis (GSEA) was performed
by using the Broad Institute GSEA application (Mootha et al.,
2003; Subramanian et al., 2005). Input lists for GSEA were ranked
based on log2-fold-change.
Transcription factor binding sites
Promoter analysis to search for overrepresented transcription fac-
tor binding sites (TFBS) was done using the Pscan web interface
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(Zambelli et al., 2009) (http://159.149.160.51/pscan/) scanning
the promoter region from −250bp to +50bp from TSS compar-
ing to JASPAR descriptors. All Gene ID conversion was done using
BioMart database queries (www.ensembl.org/biomart/).
Differential exon usage
For detection of differential exon usage the DEXSeq R-package
was used (Anders et al., 2012) with default parameters. FDR-
corrected p-value significance level was set to 0.01 for the 3M vs.
24M comparison and to 0.1 for the 3M vs. 29M comparison to
adjust for differences in library-type and sample size.
RNA-editing
Known RNA-editing positions in the mouse reference genome
(mm10/GRCm38 coordinates) were retrieved from previously
described editing sites in the mouse genome from two online
databases and two recent publications and compiled to a non-
redundant list of 17831 positions (Table S6). This list was
used as input for the REDItools algorithm REDItoolKnown.py
(Picardi and Pesole, 2013). Further input arguments were a list
of splice sites (taken from UCSC table browser), the current
genome sequence (GRCm38p2) in fasta format and the most
recent GTF file (taken from Ensembl, version GRCm38.e75).
Non-default parameters were –C 1000, –c 0, –q 10, –m 10, –v
1, –n 0.001, –t 4. For statistical comparison between groups
independent, two-sided Student’s t-tests were used for each
position.
MICROARRAY
RNA quality control, cDNA synthesis, mono-color Cy3-labeling
and hybridization to whole mouse genome microarray chips
were carried out according to Standard Operating Procedures
of the Transcriptome Core facility at University of Göttingen.
Total RNA was labeled with Cy3 according to Agilent’s Low RNA
Input Fluorescent Linear Amplification Kit and later hybridized
to Agilent Whole Mouse Genome 4 × 44K G4122F microarrays
according to the manufacturer’s protocol. Quantity and Cy3-
dye incorporation rates of the generated target material were
assessed using a NanoDrop ND-1000. Washes were performed
according to the Agilent Technologies SSPE protocol (v2.1)—
wash solution 3 was replaced by acetonitrile. After that, scanning
was performed using an Agilent G2505B scanner. Data analy-
sis was performed as described previously (Peleg et al., 2010;
Agis-Balboa et al., 2011; Kerimoglu et al., 2013). In summary,
data was analyzed using Agilent Feature Extraction software, ver-
sion 9.5.3.1 and the Limma (Smyth et al., 2005) package for
R/Bioconductor (Gentleman et al., 2004). In order to assure
that the intensities had similar distributions across arrays, VSN
normalization (Huber et al., 2002) was applied to the inten-
sity values as a method for between-array normalization. To
estimate the average group values for each gene and assess differ-
ential gene expression, a simple linear model was fit to the data,
and group-value averages and standard deviations for each gene
were obtained. To find genes with significant expression changes
between groups, empirical Bayes statistics were applied to the data
bymoderating the standard errors of the estimated values (Smyth,
2004). P-values were inferred from the moderated t-statistic and
corrected for multiple testing using the FDR method (Benjamini
and Hochberg, 1995). Afterwards, the final output was filtered for
probes showing a change in normalized intensity that was greater
than 1.414 – fold [log2(fold change) ≥ 0.5] with an adjusted
p-value of FDR(p)<0.1.
QUANTITATIVE REAL-TIME PCR (qRT-PCR)
Quantitative real-time PCR (qPCR) was performed as described
before (Peleg et al., 2010). In summary, 1μg of total RNA was
used for cDNA synthesis and cDNAwas diluted 1:10. Probe-based
qRT-PCR (UPL, Roche) was carried out on a LightCycler 480 II
(Roche) and analyzed using suppliers software. Primers used for
C4b amplification: Fwd(5′-TCTCACAAACCCCTCGACAT-3′),
Rev(5′- AGCATCCTGGAACACCTGAA-3′), UPL-Probe #10.
IMMUNOHISTOCHEMISTRY
Fluorescent staining of target proteins was performed as previ-
ously described (Peleg et al., 2010). In brief, mice were tran-
scardially perfused with 4% PFA, brains isolated and post-
fixed for another 16 h in 4% PFA. Free-floating cryosections
(30μm) were incubated with 5% goat serum for blocking and
followed by incubation with target-specific primary antibod-
ies (anti-NeuN [A60, MAB377, Merck Millipore, 1:1000, anti-
GFAP [G5601, Promega, 1:1000], anti-IBA1 [019-19741, WAKO,
1:1000]). Corresponding secondary antibodies were from life
Technologies (anti-mouse Alexa-488 labeled, A11029; anti-rabbit
Alexa-633 labeled, A21071). Images were taken on a Leica SP2
confocal microscope. Stereological analysis of the number of cells
was performed on 4 serial 40μm free-floating coronal sections
per animal which were analyzed by confocal microscopy to count
cells expressing the indicated marker. Cell number was assessed as
areal density across the CA1 region. The data was normalized to
the 3 month groups.
RESULTS
DIFFERENTIAL GENE EXPRESSION ANALYSIS IN THE AGING
HIPPOCAMPUS
Age-associated memory impairment is the result of variable com-
binations of genetic pre-disposition and environmental factors,
which eventually causes detrimental changes in cellular home-
ostasis. We therefore reasoned that a comprehensive picture of
age-related changes in transcription would be most informative
about the aging processes occurring in the brain. The hippocam-
pal formation is essential for memory function in rodents and
humans and has been linked to cognitive age-associated mem-
ory impairment (Fanselow, 2010). Thus, we performed deep
sequencing of polyA-enriched RNA extracted from the mouse
hippocampus in three different age groups (3-month-old mice,
24-month-old-mice, and 29-month-old-mice). Since C57BL/6J
mice in the laboratory have a maximum life span of just above
30 months, 24-month-old mice represent a model of advanced
aging, while 29-month-old represent a time point at the end of
life-span. We first confirmed that the selected groups of mice
indeed show age-associated memory decline (Figure 1). Due
to severely impaired locomotor activity in 29-month-old mice
we had to exclude these mice from any behavioral testing. A
commonly employed test for hippocampus-dependent memory
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FIGURE 1 | Impaired novel object recognition memory in 24-month-old
mice. (A) 3-month-old mice (3M) and 24-month-old mice (24M) were
tested in the novel object recognition paradigm. To assay short-term
memory, mice were first exposed to two similar objects (A+A) and then
re-exposed to the testing area containing one novel object 5min later
(A+B). Preference for the novel object was significantly greater in
3-month-old mice when compared to the 24-month group, which
performed at chance level (∗p < 0.05 between groups, two-sided
t-test; ##p < 0.01 vs. chance level, one-sample t-test; n = 11[3M]/9[24M]).
(B) To test long-term memory mice were exposed to the arena 24 h later,
now containing another novel object (A + C). While object preference in
3M was significantly higher than chance level (#p < 0.05, one-sample
t-test, n = 10), 24M animals (n = 4) performed at chance level, indicating
impaired long-term object recognition memory in aged mice. Error bars
indicate s.e.m. (C) During the training session, none of the groups showed
preference for any of the two equal objects (A+A).
function in mice is the Morris water maze test. Pilot experi-
ments however showed that in our hands even 24-month-old
mice have difficulties to cope with the 2-week-lasting daily train-
ing procedure, in which the animals have to swim in a pool
filled with opaque water and need to find and climb on a hid-
den platform. Thus, we decided to subject mice to the novel-
object-recognition paradigm that does not depend on advanced
motor skills and allows the measurement of short and long-
term memory in a non-stressful experimental setting. Moreover,
while object recognition learning recruits various brain struc-
tures, it also depends on an intact hippocampus (Broadbent
et al., 2010; Antunes and Biala, 2012). As expected, we observed
that both short (Figure 1A) and long-term object-recognition
memory (Figure 1B) was impaired in 24-month-old mice, when
compared to 3-month-old mice. This was not due to altered
explorative behavior during the training, since both groups of
mice explored the objects presented during the training session
to a similar degree (Figure 1C).
In the next step, we isolated total RNA from the hippocampi
of 3-, 24-, and 29-month-old mice and subjected it to RNA
sequencing. In line with previous studies, we observed that
aging was not associated with massive changes in cell number
(Long et al., 1999) (Figure S1). We first compared differential
gene expression across the different age groups using the 3-
month group as reference. 477 genes were differentially expressed
(313 up-regulated, 164 down-regulated) in 24-month-old mice
and 323 genes (275 up-regulated, 48 down-regulated) in 29-
month-old mice (Figure 2A, Table S1) when compared to the
3-month group. In all comparisons, we observed a general trend
toward higher numbers of up-regulated genes (∼70%) com-
pared to down-regulated genes (Figure 2B). When we compared
these lists among each other, we found a significant amount
of overlap between genes up-regulated at 24 and 29 months of
age (122 genes, Figure 2C, Table S1). The overlap between the
genes down-regulated in 24- and 29-month-old mice was less
pronounced (17 genes, Figure 2C, Table S1). When we analyzed
the 122 genes commonly up-regulated in 24- and 29-month-old
mice for functional pathways we observed inflammatory signal-
ing pathways, namely the “Systemic lupus erythematosus” and
the “complement and coagulation pathway” to be highly enriched
(Figure 2D, Table S2). It has to be noted that several genes of
the complement system are linked to systemic lupus erythe-
matosus, which explains the enrichment of this pathway (Table
S2). This data suggests that activation of the complement sys-
tem is one of the key features of the aging hippocampus. Similar
results were obtained when we separately analyzed all genes up-
regulated in 3 vs. 24-month-old mice (Figure 2E, left panel).
When we analyzed all up-regulated genes in 3 vs. 29-month-old
mice, we found significant enrichment of additional immune-
related pathways (Figure 2E, right panel, blue bars), suggestive
of an even more pronounced immune activation with increasing
age. Another group of up-regulated genes was associated with cell
adhesion since “cell adhesion molecules” was also identified as
a significantly enriched pathway in 24- and 29-month-old mice
(Figure 2E, Table S2).
These findings, based on analysis of lists of significantly
up-regulated genes using the DAVID platform, were further
confirmed by GSEA, an unbiased approach to analyze enrich-
ment of functional groups in a given gene list without the
need for thresholding or introduction of p-value cutoffs. Similar
to the previous analysis, we found the enriched immune sys-
tem pathways, including the top-enriched “complement and
coagulation pathway” in both aging groups (Figure 2F), as
well as several additional pathways associated with immune-
system function (Figure S2). Interestingly, several of these addi-
tional categories were associated with pathological infection
by bacteria, viruses and other pathogenic organisms, suggest-
ing that at least part of the neuroinflammatory response may
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FIGURE 2 | Aging is associated with changes in gene expression and
upregulation of immune system functions in the hippocampus.
(A) Heatmaps of differentially expressed genes in 3-month (3M) and
24-month-old mice (24M, left panel) and 3 and 29-month (29M) old mice (right
panel). High expression is marked by the red color spectrum, low expression
by blue colors. (B) Pie chart showing the percentage of genes up-and
down-regulated in 3 vs. 24/29 month-old mice. (C) Venn diagrams comparing
significantly regulated genes found in the different experiments (3M vs. 24M
and 3M vs. 29M). (D) Genes up-regulated at 24 and 29 month of age were
subjected to functional enrichment analysis for overrepresented biological
processes and KEGG pathways. (E) Fold enrichment of overrepresented KEGG
pathways in up-regulated genes when individually comparing the 3M vs. 24M
and 3M vs. 29M groups. (F) Using non-cutoff gene set enrichment analysis
(GSEA), the top up-regulated KEGG pathway was the complement and
coagulation cascade. Shown are enrichment plots along expressed genes,
(Continued)
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FIGURE 2 | Continued
ranked by fold-change [left/red: positive log2−fold-change (upregulation),
right/blue: negative log2-fold-change (downregulation); a gene contributing to
the enrichment score of the selected pathway along the ranked list is marked
by a vertical black line and increases the cumulative enrichment score (green
line)]. (G) qPCR analysis of the C4b gene (∗∗∗p < 0.001 vs. 3M group,
two-sided t-tests; #p < 0.05 vs. 24M group, two-sided t-test; n =
5[3M]/4[24M]/8[29M]). Error bars indicate s.e.m.
be attributed to the invasion of parasitic microbes across the
blood brain barrier. Furthermore, GSEA found a similar set
of additional pathways in the 29-month-old mice compared to
the 24-month group as detected by DAVID platform analy-
sis. Thus, GSEA confirmed functional enrichment of immune
system-related pathways, which are gradually up-regulated with
advancing age.
To further verify these findings we decided to reproduce the
results in an additional cohort of 3 and 29-month-old mice using
a microarray approach thereby also controlling for any potential
experimental bias that might be introduced by RNA sequenc-
ing. Albeit DEG differed to some extend, the affected pathways
were almost identical and the complement system was the most
affected pathway among the up-regulated genes (Table S2).
Within this pathway the C4b gene encoding the complement
factor 4 (C4) constantly turned up among the most significantly
up-regulated genes in all our analyses. Thus, to validate the find-
ing made by genome-wide techniques we sought to directly com-
pare expression levels of this gene among all three aging groups by
qRT-PCR. We detected a 3.2-fold increase of C4bmRNA levels in
the 24-month (24M) group and a further increase in 29-month
(29M) group (6.6-fold) when compared to the 3-month (3M)
group (Figure 2G).
We also determined functional enrichment among down-
regulated genes. Interestingly, the down-regulated genes in the
24M group were enriched for genes of the “neuroactive ligand-
receptor interaction” and “regulation of transcription” pathways,
while no pathways could be detected in the 29M group, even if
we combined the data obtained by RNA sequencing and microar-
ray (Table S2). When we combined the genes down-regulated in
24- and 29-month-old mice we observed the “neuroactive ligand-
receptor interaction” and the “calcium signaling” pathways to be
significantly affected (Table S2).
In addition to protein-coding genes, we could also detect
differential regulation of several non-coding RNAs (ncRNAs),
including the pseudogene Pisd-ps1 and the long intergenic non-
coding RNA (lincRNA) Neat1 as well as Malat1, also known
as Neat2 (Table S1). While the role of long non-coding RNAs
is only beginning to emerge, Neat1 and Malat1 are known to
accumulate in the nucleus, where they form the RNA backbone
of so-called paraspeckles, subnuclear ribonucleoprotein bodies
involved in transcriptional regulation, e.g., by nuclear retention
of RNAs (Bond and Fox, 2009). Interestingly, we could also detect
increased transcription from the C4a locus in the 29M group.C4a
is closely related to the nearby C4b but does not encode a protein,
according to the ENSEMBL database. Though their functional
significance is subject to ongoing research, these results indi-
cate that also regulatory ncRNAs are implicated in hippocampal
aging.
Taken together, analysis of differential gene expression
revealed that hippocampal aging is markedly characterized by
up-regulation of a neuroinflammatory program. Especially acti-
vation of the complement system was highly correlated with
increasing age.
AGE-ASSOCIATED CHANGES IN GENE EXPRESSION ARE
ORCHESTRATED BY A SPECIFIC SET OF TRANSCRIPTIONS FACTORS
To further elucidate potential upstream mechanisms of the iden-
tified transcriptional program, we searched the promoters of
regulated genes for common TFBS. We found a large number of
potential TFBS significantly enriched at promoters of genes that
were up-regulated with aging (Table S3). Of these, the TOP20
most strongly enriched TFBS were largely similar in the 24M and
29M group (Figures 3A,B). We could identify a number of com-
mon transcription factor families that together made up the bulk
of the significantly enriched TFBS [Signal transducer and activator
of transcription (STATs), Interferon regulatory factor (IRF), Spleen
focus forming virus proviral integration oncogene (SPI), Activator
protein 1, (AP1, composed of Fos, Jun and ATF family members),
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
κB), the GATA and the E26 transformation-specific (ETS) family
of transcription factors (Table S3)], which are strongly associ-
ated with their roles in immune-related signaling (Peng, 2008).
Of note, this set of TFs explained 44% of all up-regulated genes in
24- and 53% in 29-month-old mice. In fact, up to 87% of all up-
regulated genes could be assigned to the action of enriched TFs
(Figure 3C, Table S3).
In agreement with functional enrichment of DEG, we observed
a higher diversity of enriched TFBS in the 29M group (Figure 3B,
Table S3). While TFBS of the AP1 family were more abundant
in the 24M group, TFBS of the NF-κB and GATA families were
more abundant in the 29-month group. Notably, also the Z-scores
and significance levels for the STAT and IRF families were consid-
erably higher in the 29M group (Figures 3A,B Table S3), which
was in line with up-regulation of the Stat1 gene and several Irf
genes in the 29M group (Table S1). Together, these results sug-
gest increasing usage of STAT- and IRF-related cellular signaling
pathways in the hippocampus with increasing age.
Among down-regulated genes, significant enrichment of TFBS
was less pronounced and more heterogeneous. However, binding
sites for the E2F family of transcription factors as well as for the
specificity protein (SP) and EGR families were identified as com-
mon between the two aging groups and enrichment of EGR TFBS
among down-regulated genes correlated with down-regulation of
Egr genes in the 24-month group (Tables S1, S3).
WIDESPREAD AND SPECIFIC ALTERNATIVE EXON USAGE CHANGES IN
THE AGING HIPPOCAMPUS
Alternative to the altered expression of genes, co-transcriptional
intron excision from the nascent pre-mRNA, known as splicing,
is the main mechanism for generation of transcript isoforms and
differential exon use in information-dense and complex genomes,
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FIGURE 3 | Promoter analysis of aging-regulated genes for
overrepresented transcription factor binding sites (TFBS). (A) Z-score
(enrichments score) for different position weight matrices of known
transcription factors in the set of gene up-regulated in 3 vs. 24-month-old
mice. Higher Z-score means higher enrichment. Shown are only the top
20 most significantly enriched matrices. (B) The same analysis as
described in (A) was performed for up-regulated genes in 3 vs.
29-month-old mice. (C) Pie charts showing the percentage of differentially
expressed genes that can be explained by the selected core set of
transcription factors.
thereby adding another important level of gene expression
control.
We therefore analyzed our RNA sequencing data with respect
to differential exon usage. We found 436 annotated genes with
significant changes in exon usage in the 24M group and 80 genes
in the 29M group (Figure 4A; Table S4). Thus, changes in RNA
splicing were, at least in the 24M group, quantitatively compa-
rable to the changes observed in gene expression (Figure 4A).
However, there was little to no overlap between genes affected
by altered splicing and genes that were differentially expressed
(Figure 4B). In fact, less than 1% of the DEG were also differ-
ently spliced in the 24M group, while zero overlap was found
in the 29M group. This data indicates that differential gene
expression and alternative splicing may affect different signaling
pathways. To test this hypothesis, we analyzed the differentially
spliced genes for enrichment of functional pathways. Our anal-
ysis revealed that there was a significant overrepresentation of
genes associated with neuronal function including synaptogen-
esis, regulation of synaptic transmission, axonogenesis, neuron
projection morphogenesis, postsynaptic density and long-term
potentiation (Figure 4C, Table S5). Of note, none of these path-
ways was enriched in gene-set of DEG (Figure 4C). Vice versa,
pathways linked to inflammatory response–which dominated the
list of DEG–could not be identified within the group of alterna-
tively spliced genes (Figure 4C). These data suggest that inflam-
matory responses in the aging hippocampus are driven by changes
in differential gene expression whereas de-regulation of synaptic
plasticity in mainly attributed to differential splicing. One of the
genes that was differentially spliced in both 24- and 29-month-
old mice when compared to their young counterparts was the
Spectrin β, non-erythrocytic 1 gene (Sptbn1), that showed a specific
upregulation in usage of exon 10 with age (Figure 4D). Sptbn1 is
best known for its role in cytoskeleton regulation during neurite
outgrowth (Lee et al., 2012), which is in agreement with our pre-
vious functional enrichment analysis. The inclusion of exon 10
suggests a shift towards higher expression of Sptbn1 isoform 2,
resulting in a protein that has shorter and distinct N- and C- ter-
mini compared to isoform 1 and lacks the pleckstrin homology
(PH) domain that is critical for tethering F-actin filaments to the
plasma membrane (Figure S3).
In addition to these widespread changes, we found differential
exon usage in the amyloid beta (A4) precursor protein (App) and
the beta-site APP cleaving enzyme 1 (Bace1) genes (Table S4), both
of which are strongly implicated in the etiology of AD. This sug-
gests that also differential-splicing events that occur with aging
may be implicated with altered Aβ production in AD.
DIFFERENCES IN RNA-EDITING
A second mechanism to generate alternative transcript iso-
forms is RNA-editing. Though more subtly changing the coded
information as compared to alternative splicing, it also occurs
co-transcriptionally and may lead to altered regulation of the
transcript or a change in amino acid sequence of the encoded
protein. Notably, the mammalian, and especially the human,
brain has been identified as the principal site for RNA-editing.
Since RNA sequencing is not only able to quantify transcript
abundance but also allows visualization of the exact sequence
of these transcripts, it is possible to identify changes in tran-
script sequence from the genomic reference at known posi-
tions. We compiled a list of previously described editing sites in
the mouse genome from two online databases and two recent
publications to yield a non-redundant list of 17831 positions
(Table S6).
At 682 of the 17831 known positions, we found RNA-editing
in the 3M group (Table S7). Of these 682 positions, we found 14
editing sites in the 24M group and 41 editing sites in 29M that
showed significant change in editing frequency, corresponding to
12 and 35 genes, respectively (Figure 5A, Table S8). Interestingly,
when we compared genes that undergo altered RNA editing
in the aging hippocampus to the list of differentially expressed
and spliced genes, there was almost no overlap (Figure 5B) sug-
gesting that gene expression, splicing and RNA editing control
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FIGURE 4 | Differential exon usage and alternative splicing changes.
(A) Number of hippocampal genes affected by differential expression,
splicing or RNA-editing during aging. (B) Venn-diagrams showing the
overlap of genes affected by expression and/or splicing between age
groups. Note that there is little to no overlap. (C) Cellular pathways
affected in 3- vs. 24/29-month-old mice by splicing or expression
levels. The data on differential expression is based on all up- or
down-regulated genes. (D) One of the overlapping genes was
Spectrin β, non-erythrocytic 1 (Sptbn1), showing higher expression of
exon 10 (pink box) in aged mice, suggesting higher abundance of
the transcript isoform 2 (see Figure S2 for details on isoform and
domain structure).
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FIGURE 5 | RNA editing in the aging hippocampus. (A) Total number of
RNA-editing events detectable in the hippocampus of 3-month-old mice and
number of changes occurring during aging. (B) Venn diagram showing the
overlap of differentially expressed genes, genes affected by splicing and
RNA-editing in 24-month-old mice (upper panel) and 29-month-old mice
(lower panel). (C) Editing of the pseudogene-transcribed ncRNA Pisd-ps1
within exon 1 was found to be significantly increased in the 29M group
(D) Within the well-described editing cassette of the Htr2c mRNA, editing
was significantly upregulated at position D (∗p < 0.05, n = 3 per group). Error
bars indicate s.e.m.
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distinct cellular pathways in the aging hippocampus. Only one
of the genes that was characterized by altered RNA editing in
29-month-old mice was also up-regulated at the gene expression
level (Figure 5C). This gene (Pisd-ps1) codes for a non-coding
RNA expressed from a pseudogene with unknown function.
We also found increased editing of the well-established RNA-
editing target serotonin receptor 2c (Htr2c) (Figure 5D). It has
been shown that increased editing of the Htr2c mRNA leads to
a decrease in the receptor’s signaling fidelity, which is in line with
declining function of the serotonergic system with aging (Fidalgo
et al., 2013). Moreover, altered RNA-editing of the Htr2c gene
was observed in a mouse model for impaired memory function
(Stilling et al., 2014).
Another gene that showed higher editing frequency with aging
was Slc7a2, also known as Cat2 or Ctn. Interestingly, it has been
described in the literature that theCtn isoform of this gene under-
goes nuclear retention and becomes part of paraspeckles (Bond
and Fox, 2009), supporting the previous observation that aging is
accompanied by increased nuclear paraspeckle formation.
In summary, our results suggest that hippocampal aging cor-
relates to different degrees with altered gene expression, RNA
splicing and RNA editing. Of note all of these processes appear
to specifically account for age-associated changes in distinct cel-
lular pathways. Namely, the induction of inflammatory processes
is linked to altered gene expression while decline of synaptic
plasticity seems to be mainly due to differential splicing.
DISCUSSION
In the present study we performed RNA sequencing in the
hippocampus of three different aging groups to determine dif-
ferential gene expression, exon usage and RNA-editing. Though
brain aging has previously been described to go along with tran-
scriptional changes, a detailed, homogenous picture of the tran-
scriptome of the agingmouse hippocampus, especially toward the
end of an individual’s life span using RNA sequencing, has not
been drawn yet.
Several studies have used microarray approaches to investigate
age-associated transcriptional profiles of different brain regions
in different species and came to heterogeneous results (Finch and
Morgan, 1990; Pletcher et al., 2002; Blalock et al., 2003, 2010; Lu
et al., 2004; Verbitsky et al., 2004; Xu et al., 2007; Zahn et al.,
2007; Loerch et al., 2008; Pawlowski et al., 2009; Bishop et al.,
2010), which may in part reflect differences in the technology
available and also limited information on the mouse genome
and transcriptome at the time the corresponding studies were
conducted.
When we analyzed differential gene expression among the dif-
ferent age groups, the most striking effect was the up-regulation
of genes linked to inflammatory processes with the comple-
ment system being the top ranking pathway identified by gene-
set enrichment, as well as pathway analysis using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) database. Increased
neuroinflammation is likely the result of multiple up-stream fac-
tors such as impaired blood-brain barrier function (Lynch and
Johnson, 2012; Erickson and Banks, 2013) leading to increased
invasion of peripheral bacteria and viruses as well as cells of the
peripheral immune system, which will cause a defense response
against these invaders (Blau et al., 2012; Marques et al., 2013).
Moreover, increased clearance of damaged or misfolded proteins
and other cellular debris becomes necessary with increasing age
and these aggregates will activate the immune system (predom-
inantly microglia) (Fonseca et al., 2004; Czirr and Wyss-Coray,
2012).
Of note, up-regulation of neuroinflammatory genes with aging
clearly delivers an explanation why neurodegenerative diseases
such as AD become increasingly abundant with advanced age.
Based on our findings, we derive the hypothesis that disease-
related mutations become only detrimental when the respec-
tive genes become expressed or activated. As such, aging is the
strongest risk factor for AD (Lopez, 2011). The reason why late-
onset AD (LOAD) is associated with increasing age is not yet
fully understood. However, accumulating evidence and a plethora
of genome-wide association studies (GWAS) link LOAD to a
fast growing number of genetic risk factors and it seems feasi-
ble that these genetic risk factors result in LOAD due to changes
at the transcriptome and proteome level. Indeed, in our hip-
pocampal aging study in mice, we found up-regulation of several
homologs, interaction partners or other closely related genes to
almost all genes that appear to be the top 10 single genetic risk
factors for LOAD as designated by the AlzGene database (Bertram
et al., 2007). Of particular interest in light of our data is the
gene coding for complement receptor 1 (CR1), since this recep-
tor binds processed C4 and C3 complement proteins including
the products of the C4b gene, which we found to be most promi-
nently up-regulated in the aging hippocampus. Single nucleotide
polymorphisms (SNPs) and copy number variations (CNVs) in
the human CR1 gene were found to be highly associated with
late onset AD in a number of studies and across ethnic groups
(Bertram et al., 2007; Lambert et al., 2009; Biffi et al., 2010,
2012; Carrasquillo et al., 2010; Chibnik et al., 2011; Brouwers
et al., 2012; Crehan et al., 2012; Hazrati et al., 2012; Keenan
et al., 2012; Ma et al., 2014). This makes it very tempting to
draw the conclusion that increased expression of C3 and C4
with aging will result in aberrant regulation of the complement
cascade, which in turn lead to neurodegeneration in carriers of
the “wrong” CR1 allele. Aberrant regulation could lead to neu-
rodegeneration in two different, non-mutual exclusive ways. On
the one hand, differential CR1 regulatory activity could lead
to less effective Aβ aggregate clearance (Fonseca et al., 2004).
On the other hand, de-regulated activation of the complement
system could result in collateral damage by overactive inflam-
mation (reviewed in Czirr and Wyss-Coray, 2012). Along this
line, CR1 inhibition was shown to prevent microglia activation
(Crehan et al., 2013). Of note, mice do not express CR1 but
mice that lack the murine ortholog Cr1-related protein Y (Crry)
show reduced inflammatory responses and attenuated increases
in AD-related disease progress biomarkers (Killick et al., 2013),
further suggesting that activation of the complement system is a
key feature of the aging hippocampus that also plays a role in AD
pathogenesis.
The exact mechanism of altered CR1 regulatory function in
this complex network is still to be elucidated but a beneficial
effect of complement inhibition in general has been demon-
strated (Rancan et al., 2003; Fonseca et al., 2004; Leinhase et al.,
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2006; Kulkarni et al., 2008, 2011; Pillay et al., 2008), yet this data
remains controversial (Wyss-Coray et al., 2002; Loeffler, 2004;
Maier et al., 2008). Nevertheless, our data support the view that
targeting the complement system and other inflammatory path-
ways poses an intriguing possibility for the treatment of aging-
associated diseases and cognitive decline, which has recently been
demonstrated for inhibition of NF-κB signaling in amousemodel
of AD (Liu et al., 2014). Likewise, physical activity in rodents
and humans has been shown to improve cognitive abilities dur-
ing aging (van Praag et al., 1999; Praag et al., 2005; Erickson
et al., 2011). Remarkably, a recent study could show in aged mice
that voluntary wheel running leads to a reduction in C4b expres-
sion in the hippocampus (Kohman et al., 2011), demonstrating a
clear correlation between C4 levels and cognitive abilities, which
is further supported by the finding that C4 inhibition by external
application of a vaccinia virus complement control protein has
beneficial effects on memory performance in mouse models of
AD (Kulkarni et al., 2008, 2011).
While it is not entirely clear if the age-associated induction of
immune genes is cause or consequence of altered glia cell function
that arise on the background of altered activity and/or increased
cell number (Lolova, 1991; Amenta et al., 1998; Long et al., 1999;
Blalock et al., 2003; Takahashi et al., 2006; Hayakawa et al., 2007)
astrocytes and especially microglia are clearly good candidates for
a potent source of immune system molecules (Hosokawa et al.,
2003). We did not observe significant changes in the number of
neurons, astrocytes or microglia in our study. In line with this,
the corresponding marker genes for neurons and microglia were
not altered in our gene-expression analysis. The astrocyte marker
gene gfap was however increased during aging, indicating that
the inflammatory response in our study in mainly linked to a
change in the active state of glia cells. However, also neurons are
known to secrete complement proteins (Shen et al., 1997; Terai
et al., 1997; Hosokawa et al., 2003) and future studies should
therefore also focus on untangling which cell types are the main
contributors to the observed neuroinflammatory program. In any
case C4b is an interesting gene, since its expression strongly cor-
related with age and it was in fact one of the most significant
changes that have been reported by others and within this study.
It was already found to be up-regulated as one of the very few
DEGs in the comparison of hippocampal expression in 3-month-
old mice with 16-month-old mice (3-fold up- regulation) (Peleg
et al., 2010). Interestingly, out of the 12 up-regulated genes found
in this independent study, 6 genes were also found up-regulated
in the present study. Along with C4b and C3—another com-
plement component frequently found up-regulated—these were
1700112E06Rik, BC061194, Cox8b and Sult1c2. Hence, these 6
genes obviously belong to a set of genes that are highly associ-
ated with murine hippocampal aging. In addition, other studies
have observed complement-gene up-regulation in studies of aging
in the hippocampus as well as in the prefrontal cortex (Verbitsky
et al., 2004; Reichwald et al., 2009; Bordner et al., 2011; Stephan
et al., 2013).
To our knowledge, the present study is the first to also specif-
ically report the role of long-non-coding RNAs in the aging
hippocampus. We found several long-non-coding RNAs to be
differentially expressed. Little is known so far on the role of
these RNAs, but the up-regulation of Neat1 and the associated
ncRNA Malat1 was interesting since Malat1 is highly abundant
in neurons and has been associated with the regulation of gene
expression and splicing, but was also found to affect the expres-
sion of genes linked to synaptic function (Bernard et al., 2010).
Of note, a previous study reported that Malat1 is increased in
the hippocampus of alcoholics (Kryger et al., 2012), a condi-
tion clearly linked to cognitive impairment. Another interesting
finding was the up-regulation of Pisd-ps1. Though the Pisd-ps1
ncRNA has no annotated function so far, it has been described
to be up-regulated with aging (Bordner et al., 2011; Sousa-Victor
et al., 2014). Pisd-ps1 also harbors a known RNA-editing site
and was one of the few transcripts that show a higher editing
frequency in 29-month-old mice. Thus, this ncRNA might be
implicated in brain aging and warrants further research on its
regulatory functions.
To obtain more insight on the mechanisms that drive age-
associated changes in hippocampal gene expression, we analyzed
the promoters of the differentially regulated transcripts.We found
high enrichment of TFBS involved in pro-inflammatory signaling
cascades. This trend was even more pronounced in 29-month-old
mice, which supports our interpretation of increasing neuroin-
flammation with advancing age as part of the aging program.
One of the key factors contributing to the neuroinflammatory
gene expression response in the aging hippocampus was STAT1.
Interestingly, mice that lack STAT1 show enhanced memory per-
formance and are resistant tomemory impairment induced by Aß
peptides injected into the hippocampus (Hsu et al., 2014). Thus,
activation of STAT1might be a key step in age-associatedmemory
impairment.
RNA sequencing also allows the analysis of differential splic-
ing events and previous data suggest that differential exon
usage undergoes substantial changes during brain development
(Tollervey et al., 2011; Mazin et al., 2013). Differential splicing
has also been observed in postmortem brain tissue from patients
that suffered from sporadic AD (Twine et al., 2011; Mills et al.,
2013) and in mouse models for amyloid deposition (Kim et al.,
2012). This data is in line with increased protein levels of spliceo-
some components in AD patients (Bai et al., 2013). However,
RNA sequencing has not been used to analyze changes in the
aging hippocampus as described in this study. The first interest-
ing observation is that massive changes in RNA splicing occur
when we compared the hippocampus of 3-month-old mice to the
24- and 29-month groups. Another highly interesting observation
was that there was little to no overlap among the genes differ-
entially expressed and the genes that were differentially spliced
during aging. The most striking finding is, however, that genes
affected by age-associated changes in splicing were associated with
neuronal and synaptic function, including neurite outgrowth and
LTP. This is in line with the well-described decline in synaptic
plasticity with aging (Blau et al., 2012). A number of interest-
ing candidate genes were identified and await further analysis. For
example, we identified Spectrin β, non-erythrocytic 1 (Sptbn1) to
be differentially spliced during aging. Sptbn1 is involved in teth-
ering the actin cytoskeleton to the plasma membrane, which is
necessary for neurite outgrowth and possibly spine morphology
and motility (Lee et al., 2012). Interestingly, introduction of the
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observed exon change in this gene may indicate a shift toward an
isoform that cannot perform this function anymore, since it lacks
the essential membrane-tethering PH protein domain. Together,
these results confirm findings in the literature and make differen-
tial exon usage analysis a plausible tool for the study of age-related
changes in the transcriptome. The fact that the age-associated
inflammatory response is driven by changes in gene expression
that could be linked to a number of key transcription factors
while genes linked to synaptic plasticity are mainly affected by
alternative splicing also suggests that functionally distinct gene
expression programs in the adult brain are regulated by specific
mechanisms.
In conclusion, our data deciphers at an unprecedented depth
the hippocampal transcriptional program linked to aging. While
changes in the absolute levels of RNA transcripts are linked to
an inflammatory response and especially activation of the com-
plement system, changes in alterative splicing affect genes linked
to synaptic plasticity. At the same time RNA editing does not
appear to play a major, genome-wide role in the aging hip-
pocampus. This data provides important novel information, and
multiple starting points for further analysis of potential thera-
peutic interventions and strongly suggests a causal relationship
between aging-dependent changes in gene expression and the late
onset of neurodegenerative diseases, most prominently AD.
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Figure S1 | Immunohistochemical analysis of hippocampal cell number.
(A) Representative images showing immunostaining for the Neuronal
maker protein Neuronal N (NeuN), the Microglia marker Ionized calcium
binding adaptor molecule 1 (IBA1) and the astrocyte marker Glial fibrillary
acidic protein (GFAP) in 3 and 29-month old mice. (B) Quantification of A.
CA1; hippocampal subregion CA1, cc; corpus calosum. Scale bar: 100μm.
Figure S2 | Functionally enriched pathway in 3 vs. 24 and 29 month old
mice identified on the basis of gene array data. Left panel: Enriched
pathways identified on the basis of differentially expressed genes
comparing hippocampal RNA from 3- vs. 24-month-old mice. Right panel:
Enriched pathways identified on the basis of differentially expressed
genes comparing hippocampal RNA from 3 vs. 29-month-old mice.
Figure S3 | Genetic architecture and domain structure of Sptbn1. The
figure was downloaded from the ENSEMBLE database (version e76). It
shows the genomic locus of Sptbn1 and its annotated transcribed
isoforms including exon structure and encoded protein domains. Isoform
2 is marked in yellow. This was the isoform that is likely underlying the
switch in exon usage detected in RNA-seq data in 24M and 29M groups.
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